Financial Highlights of Aristo Bio-Tech and Lifescience Ltd
Gujarat-based Aristo Bio-Tech and Lifescience Ltd, a rapidly growing company in the agrochemical and biotechnology sector, has announced impressive financial results for the fourth quarter and full financial year ending March 31, 2025 (FY25). The company achieved a significant turnaround in profitability, accompanied by substantial revenue growth.
Key financial highlights include a notable increase in revenue, contributing to the company’s strong financial performance. However, due to business expansion and heightened capital expenditure, depreciation rose by Rs. 1 crore compared to the previous year. This increase in depreciation resulted in a lower visible profit, despite the overall positive financial trajectory.
The company’s financial performance reflects its successful strategies in the agrochemical and biotechnology space. Aristo Bio-Tech’s ability to grow revenue while managing expenses demonstrates its potential for continued growth in the industry.
Source: Company financial report
